AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8925993 — intervention group
Group type: EXPERIMENTAL
Intervention: Children from mothers with EPH gestosis
Number of subjects: 61
Study 8925993 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy women and their children)
Number of subjects: 61
Study 1477436 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous adenosine 140 micrograms/kg/min for six minutes
Number of subjects: 15
Study 1477436 — intervention group
Group type: COMPARATOR
Intervention: Oral dipyridamole suspension 300 mg
Number of subjects: 15
Study 1477436 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous adenosine
Number of subjects: 15
Study 1477436 — intervention group
Group type: COMPARATOR
Intervention: Oral dipyridamole
Number of subjects: 15
Study 1477436 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous adenosine and oral dipyridamole
Number of subjects: 15
Study 6693039 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 18
Study 6693039 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 18
Study 31407953 — intervention group
Group type: EXPERIMENTAL
Intervention: Father-daughter communication
Number of subjects: 193
Study 31407953 — intervention group
Group type: COMPARATOR
Intervention: Communication style
Number of subjects: 193
Study 29649227 — intervention group
Group type: EXPERIMENTAL
Intervention: Cleaner burning biomass-fuelled cookstoves
Number of subjects: 6168
Study 29649227 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 6168
Study 27955682 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealthcare (Telekit) solution
Number of subjects: 600
Study 27955682 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 600
Study 25217762 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal fluency task that elicited analytic thinking (Study 2)
Number of subjects: 990
Study 25217762 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive disfluency method to elicit analytic thinking (Study 3)
Number of subjects: 990
Study 25217762 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive disfluency method to elicit analytic thinking (Study 4)
Number of subjects: 990
Study 21805226 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP + exercise
Number of subjects: 32
Study 21805226 — intervention group
Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 32
Study 20551752 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple target regimen (amplitude-modulated medium-frequency stimulation + EMG-biofeedback)
Number of subjects: 158
Study 20551752 — intervention group
Group type: COMPARATOR
Intervention: EMG-biofeedback alone
Number of subjects: 158
Study 20551752 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple target regimen
Number of subjects: 158
Study 17534955 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole
Number of subjects: 0
Study 17534955 — intervention group
Group type: COMPARATOR
Intervention: Levodopa
Number of subjects: 0
Study 15611784 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin capsules (0.9 g red pepper; 0.25% capsaicin; 80,000 Scoville Thermal Units)
Number of subjects: 24
Study 15611784 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin in tomato juice (0.9 g red pepper; 0.25% capsaicin; 80,000 Scoville Thermal Units)
Number of subjects: 24
Study 15611784 — intervention group
Group type: COMPARATOR
Intervention: Placebo (offered in tomato juice or capsules)
Number of subjects: 24
Study 15611784 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin conditions (both oral and gastrointestinal)
Number of subjects: 24
Study 12198030 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 0.25 mg/kg
Number of subjects: 35
Study 12198030 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 35
Study 10417874 — intervention group
Group type: EXPERIMENTAL
Intervention: Ajoene (0.6%, gel)
Number of subjects: 60
Study 10417874 — intervention group
Group type: COMPARATOR
Intervention: Terbinafine (1%, cream)
Number of subjects: 60
Study 8524604 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation of the tibialis anterior muscle for 4 weeks at twice the motor threshold
Number of subjects: 7
Study 8524604 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation of the tibialis anterior muscle
Number of subjects: 7
Study 8524604 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation for 4 weeks at twice motor threshold
Number of subjects: 7
Study 2196942 — intervention group
Group type: EXPERIMENTAL
Intervention: High S-phase fraction tumors
Number of subjects: 430
Study 2196942 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA aneuploidy
Number of subjects: 430
Study 2196942 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive nodes, large tumor size, DNA aneuploidy, high S-phase fraction, high grade of malignancy, lack of tubule formation, high mitotic index, pleomorphism, multifocal cancer, vascular invasion
Number of subjects: 430
Study 2196942 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastosis and presence of estrogen and progesterone receptors
Number of subjects: 430
Study 2196942 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymph node status, tumor size, S-phase fraction, multifocal growth pattern
Number of subjects: 430
Study 6270950 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (2.5 microgram/kg i.v.)
Number of subjects: 16
Study 6270950 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 31502873 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance-based social skills interventions (SSIs)
Number of subjects: 0
Study 28401851 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular home-visiting during pregnancy and the first year of life
Number of subjects: 117
Study 28401851 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 117
Study 25948515 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused extracorporeal shock wave therapy (0.25 mJ/mm(2)) with three sessions of 2000 impulses in weekly intervals
Number of subjects: 250
Study 25948515 — intervention group
Group type: COMPARATOR
Intervention: Placebo intervention
Number of subjects: 250
Study 25948515 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused extracorporeal shock wave therapy (0.25 mJ/mm(2))
Number of subjects: 250
Study 23624419 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin 50mg twice a day in addition to metformin
Number of subjects: 171
Study 23624419 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin+metformin
Number of subjects: 171
Study 23624419 — intervention group
Group type: COMPARATOR
Intervention: Placebo+metformin
Number of subjects: 171
Study 21784309 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium tablet (600 mg once daily as CaCO3)
Number of subjects: 40
Study 21784309 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablet once daily
Number of subjects: 40
Study 18795291 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib 50 mg daily with standard-dose cetuximab
Number of subjects: 40
Study 18795291 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab 10 mg/kg biweekly
Number of subjects: 40
Study 16915874 — intervention group
Group type: EXPERIMENTAL
Intervention: Work-related stress management program for 12 weeks
Number of subjects: 29
Study 16915874 — intervention group
Group type: COMPARATOR
Intervention: No treatment for 12 weeks
Number of subjects: 29
Study 15553594 — intervention group
Group type: EXPERIMENTAL
Intervention: n‐3 PUFA 6.6 g
Number of subjects: 60
Study 15553594 — intervention group
Group type: EXPERIMENTAL
Intervention: n‐3 PUFA 2.0 g
Number of subjects: 60
Study 15553594 — intervention group
Group type: COMPARATOR
Intervention: Olive oil
Number of subjects: 60
Study 11033400 — intervention group
Group type: EXPERIMENTAL
Intervention: Foldable silicone intraocular lens (Allergan SI‐30) through a 3.2 mm incision
Number of subjects: 30
Study 11033400 — intervention group
Group type: COMPARATOR
Intervention: Poly(methyl methacrylate) (PMMA) intraocular lens through a 5.0 mm incision
Number of subjects: 30
Study 9062368 — intervention group
Group type: EXPERIMENTAL
Intervention: oral acyclovir 400 mg PO twice a day
Number of subjects: 27
Study 9062368 — intervention group
Group type: COMPARATOR
Intervention: viral isolation
Number of subjects: 27
Study 8444263 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory reaction time task while maintaining upright posture on a force platform; conditions of vision/surface not specified.
Number of subjects: 0
Study 3756583 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergonovine
Number of subjects: 34
Study 3756583 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 34
Study 3756583 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold pressor test
Number of subjects: 34
Study 30852173 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message reminders
Number of subjects: 187
Study 30852173 — intervention group
Group type: COMPARATOR
Intervention: No text message reminders (Control)
Number of subjects: 187
Study 29071464 — intervention group
Group type: EXPERIMENTAL
Intervention: Overnight fasting
Number of subjects: 0
Study 29071464 — intervention group
Group type: COMPARATOR
Intervention: Glucagon infusion (elevated blood glucose levels)
Number of subjects: 0
Study 29071464 — intervention group
Group type: EXPERIMENTAL
Intervention: Low blood glucose after fasting
Number of subjects: 0
Study 27423168 — intervention group
Group type: EXPERIMENTAL
Intervention: Light intensity exercise (rating of perceived exertion 11)
Number of subjects: 24
Study 27423168 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise (rating of perceived exertion 13)
Number of subjects: 24
Study 27423168 — intervention group
Group type: EXPERIMENTAL
Intervention: Hard intensity exercise (rating of perceived exertion 15)
Number of subjects: 24
Study 27423168 — intervention group
Group type: COMPARATOR
Intervention: Quiet rest (control group)
Number of subjects: 24
Study 24815594 — intervention group
Group type: EXPERIMENTAL
Intervention: Training and experimental neck pain
Number of subjects: 3
Study 24815594 — intervention group
Group type: COMPARATOR
Intervention: Training and no pain
Number of subjects: 3
Study 24815594 — intervention group
Group type: COMPARATOR
Intervention: Pain and no training
Number of subjects: 3
Study 22863265 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin combined with PEG‐IFN/ribavirin
Number of subjects: 101
Study 22863265 — intervention group
Group type: COMPARATOR
Intervention: PEG‐IFN/ribavirin without fluvastatin
Number of subjects: 101
Study 20671564 — intervention group
Group type: EXPERIMENTAL
Intervention: HEART intervention (8 structured nurse education visits and telemonitoring)
Number of subjects: 24
Study 20671564 — intervention group
Group type: COMPARATOR
Intervention: Usual care and telemonitoring (control)
Number of subjects: 24
Study 17938811 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower tertile platelet count (<198 x 10(9)/L)
Number of subjects: 5256
Study 17938811 — intervention group
Group type: EXPERIMENTAL
Intervention: Middle tertile platelet count (198-244 x 10(9)/L)
Number of subjects: 5256
Study 17938811 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper tertile platelet count (>244 x 10(9)/L)
Number of subjects: 5256
Study 17938811 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet count
Number of subjects: 5256
Study 16304303 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep-breathing exercises
Number of subjects: 90
Study 16304303 — intervention group
Group type: COMPARATOR
Intervention: Control group (no breathing exercises)
Number of subjects: 90
Study 11911935 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g amino-acid drink without tryptophan (depletion condition)
Number of subjects: 18
Study 11911935 — intervention group
Group type: COMPARATOR
Intervention: 50 g amino-acid drink with tryptophan (placebo condition)
Number of subjects: 18
Study 9717598 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine (30 micrograms.kg‐1)
Number of subjects: 60
Study 9717598 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem (0.2 mg.kg‐1)
Number of subjects: 60
Study 9717598 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 60
Study 7900508 — intervention group
Group type: EXPERIMENTAL
Intervention: IVF
Number of subjects: 90
Study 7900508 — intervention group
Group type: COMPARATOR
Intervention: Control (non-IVF infertility patients with singleton pregnancies and women with normal fertility with twin or triplet pregnancies)
Number of subjects: 90
Study 2748310 — intervention group
Group type: EXPERIMENTAL
Intervention: Catch trial (CT) group
Number of subjects: 48
Study 2748310 — intervention group
Group type: COMPARATOR
Intervention: No catch trial (no-CT) group
Number of subjects: 48
Study 334028 — intervention group
Group type: EXPERIMENTAL
Intervention: Oestriol succinate therapy (2 mg/day)
Number of subjects: 27
Study 334028 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 27
Study 334028 — intervention group
Group type: EXPERIMENTAL
Intervention: Oestriol succinate therapy
Number of subjects: 27
Study 31468735 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive Cue condition (Cue)
Number of subjects: 35
Study 31468735 — intervention group
Group type: COMPARATOR
Intervention: No-Cue condition (No-Cue)
Number of subjects: 35
Study 31468735 — intervention group
Group type: COMPARATOR
Intervention: Typically Developing Controls (TD)
Number of subjects: 35
Study 31272988 — intervention group
Group type: EXPERIMENTAL
Intervention: VRC07-523LS
Number of subjects: 35
Study 31272988 — intervention group
Group type: EXPERIMENTAL
Intervention: PGT121
Number of subjects: 35
Study 31272988 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 28408545 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted service involving a pharmacist integrated into a medical centre to assist patients after hospitalisation; includes follow-up and medication reconciliation.
Number of subjects: 2240
Study 28408545 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group) where patients self-organise a visit to their GP after hospital discharge.
Number of subjects: 2240
Study 28408545 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost analysis comparing healthcare costs associated with the intervention to those of usual care.
Number of subjects: 2240
Study 26261095 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral intervention
Number of subjects: 146
Study 26261095 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 146
Study 23886520 — intervention group
Group type: EXPERIMENTAL
Intervention: High n-3 plus low n-6 (H3-L6) intervention
Number of subjects: 67
Study 22080459 — intervention group
Group type: EXPERIMENTAL
Intervention: e-learning intervention (1-2 hours duration)
Number of subjects: 162
Study 22080459 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 162
Study 18410408 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept 25 mg twice weekly
Number of subjects: 60
Study 18410408 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral acitretin 0.4 mg kg(‐1) daily
Number of subjects: 60
Study 18410408 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept 25 mg once weekly plus acitretin 0.4 mg kg(‐1) daily
Number of subjects: 60
Study 16338779 — intervention group
Group type: EXPERIMENTAL
Intervention: Butoconazole nitrate 2% Site Release vaginal cream
Number of subjects: 181
Study 16338779 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole 150 mg tablets
Number of subjects: 181
Study 12017904 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg, as a single dose, administered either 2 hours prior or immediately before the surgical procedure
Number of subjects: 15
Study 12017904 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg
Number of subjects: 15
Study 10450625 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (30 or 60 mg daily)
Number of subjects: 253
Study 10450625 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 253
Study 7796794 — intervention group
Group type: EXPERIMENTAL
Intervention: HIGH stimulation
Number of subjects: 16
Study 7796794 — intervention group
Group type: COMPARATOR
Intervention: LOW stimulation
Number of subjects: 16
Study 7796794 — intervention group
Group type: EXPERIMENTAL
Intervention: Both HIGH and LOW stimulation
Number of subjects: 16
Study 7796794 — intervention group
Group type: EXPERIMENTAL
Intervention: After 9 months of VNS
Number of subjects: 16
Study 2241443 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillation
Number of subjects: 141
Study 2241443 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymptomatic cerebral infarction in patients older than 65 years with a left atrial diameter greater than 5.0 cm
Number of subjects: 141
Study 2241443 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymptomatic cerebral infarction in patients younger than 65 years with a left atrial diameter less than 5.0 cm
Number of subjects: 141
Study 2241443 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymptomatic cerebral infarction in patients with only one risk factor (age or left atrial diameter)
Number of subjects: 141
Study 2241443 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic nonvalvular atrial fibrillation
Number of subjects: 141
Study 2241443 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent nonvalvular atrial fibrillation
Number of subjects: 141
Study 464564 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 87
Study 464564 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosamicin
Number of subjects: 87
Study 464564 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study 30325445 — intervention group
Group type: COMPARATOR
Intervention: Diet with 0.096% Trp
Number of subjects: 270
Study 30325445 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with 0.116% Trp
Number of subjects: 270
Study 30325445 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with 0.136% Trp
Number of subjects: 270
Study 30325445 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with 0.156% Trp
Number of subjects: 270
Study 30325445 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with 0.176% Trp
Number of subjects: 270
Study 30325445 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with 0.196% Trp
Number of subjects: 270
Study 30325445 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear broken line model
Number of subjects: 270
Study 28794253 — intervention group
Group type: EXPERIMENTAL
Intervention: Midodrine only
Number of subjects: 87
Study 28794253 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridostigmine only
Number of subjects: 87
Study 28794253 — intervention group
Group type: EXPERIMENTAL
Intervention: Midodrine + Pyridostigmine
Number of subjects: 87
Study 28794253 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 87
Study 25951410 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating marshmallows (3 marshmallows three times daily)
Number of subjects: 28
Study 25951410 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating marshmallows
Number of subjects: 28
Study 23157581 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (3-25 mg/kg/day)
Number of subjects: 55
Study 22195380 — intervention group
Group type: EXPERIMENTAL
Intervention: Atraumatic Restorative Treatment (ART) restorations with conditioners (GC Dentine Conditioner)
Number of subjects: 186
Study 22195380 — intervention group
Group type: COMPARATOR
Intervention: Atraumatic Restorative Treatment (ART) restorations without conditioners
Number of subjects: 186
Study 18982338 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture
Number of subjects: 123
Study 18982338 — intervention group
Group type: COMPARATOR
Intervention: NSAID (diclofenac 3 x 50 mg oral)
Number of subjects: 123
Study 18982338 — intervention group
Group type: COMPARATOR
Intervention: Non-specific control points (acupuncture)
Number of subjects: 123
Study 17003602 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance-based PR program plus resistance training (RT)
Number of subjects: 20
Study 17003602 — intervention group
Group type: COMPARATOR
Intervention: Endurance-based PR program (ET)
Number of subjects: 20
Study 15991780 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-delivered intervention including tailored information, assessment of withdrawal, offer of nicotine replacement therapy, booklets, and a discharge letter.
Number of subjects: 1422
Study 15991780 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care).
Number of subjects: 1422
Study 12630068 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete testosterone suppression therapy
Number of subjects: 21
Study 12630068 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 21
Study 9527278 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) administered intravenously after dialysis
Number of subjects: 15
Study 9527278 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo) administered intravenously after dialysis
Number of subjects: 15
Study 7885125 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotrimoxazole (160 mg trimethoprim, 800 mg sulphamethoxazole)
Number of subjects: 40
Study 7885125 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 2221512 — intervention group
Group type: EXPERIMENTAL
Intervention: IV metoclopramide 10 mg
Number of subjects: 50
Study 2221512 — intervention group
Group type: COMPARATOR
Intervention: IV normal saline (Control)
Number of subjects: 50
Study 390339 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol administered once a day
Number of subjects: 15
Study 390339 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol administered twice a day
Number of subjects: 15
Study 390339 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol combined with a diuretic
Number of subjects: 15
Study 30836637 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet-induced weight loss after 12 weeks (NAFLD: 4.8 ± 0.5%, No NAFLD: 5.1 ± 0.5%)
Number of subjects: 143
Study 30836637 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet-induced weight loss after 50 weeks (NAFLD: 3.5 ± 0.7%, No NAFLD: 3.5 ± 0.9%)
Number of subjects: 143